Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotypic vs Phenotypic Guided Therapy for H. pylori
NCT03555526Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Dec 2017
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, amoxicillin, levofloxacin, clarithromycin, metronidazole in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
esomeprazoleamoxicillinlevofloxacinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03555526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03555526.